Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CipherTechs is a global cybersecurity services provider that specializes in managed security, digital forensics, and risk compliance. Founded in 2001 and headquartered in New York, the company offers a comprehensive suite of offensive and defensive security solutions, including Managed Detection and Response (MDR) and penetration testing. In February 2023, CipherTechs was acquired by CyberMaxx, a portfolio company of Periscope Equity, to integrate its forensic and offensive capabilities into a broader tech-enabled security platform. While the company operates primarily in the information technology sector, it maintains a significant presence in the healthcare industry by providing specialized cybersecurity and compliance services to hospitals and pharmaceutical firms. CipherTechs is recognized for its 'hacker mindset' approach to defense, helping organizations protect sensitive data and maintain regulatory standards such as GDPR and HIPAA.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CipherTechs.